PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that it will be launching version 8.0 of its D360 R&D “big data” platform for the biopharmaceutical industry at the 22nd International Molecular Medicine Tri-Conference to be held Feb. 15-20 at the Moscone North Convention Center in San Francisco.
Certara’s D360 R&D data platform solves big data challenges faced by scientists and IT staff throughout biopharmaceutical organizations by integrating and leveraging the large amount of diverse scientific data generated by sponsor companies and their outsourced partners to optimize crucial R&D decisions.
Help employers find you! Check out all the jobs and post your resume.
Certara’s D360 R&D data platform solves big data challenges faced by scientists and IT staff throughout biopharmaceutical organizations by integrating and leveraging the large amount of diverse scientific data generated by sponsor companies and their outsourced partners to optimize crucial R&D decisions.
Help employers find you! Check out all the jobs and post your resume.
